Molecule AG

Molecule AG is a decentralized biotech protocol focused on empowering science by building a Web3 marketplace for research-related intellectual property (IP). Their platform, Catalyst, aims to address the inefficiencies of traditional research funding by connecting researchers with funders, allowing for direct funding of projects through tokenized IP rights. This incentivizes collaboration and transparency, accelerating scientific progress.

Molecule's core innovation is the IP-NFT, a novel framework that combines legal IP agreements with blockchain technology to create a liquid and transactable form of ownership for research assets. By enabling fractional ownership and community governance, IP-NFTs empower researchers to fundraise commercially, engage stakeholders directly, and foster collaboration with other researchers. Molecule is building a future where scientific discovery is democratized, with patients, researchers, and funders all benefiting from a more efficient and equitable drug development ecosystem.

Molecule offers a flexible work environment, with the option for both remote and in-office positions. The company is based in Berlin, but employees can work remotely, and the company also offers paid travel to Europe and the US for conferences and hackathons. This flexibility allows employees to balance their work and personal lives, and to grow professionally by attending industry events.

Molecule AG offers a competitive compensation package based on salary research conducted across four continents, opportunities for career progression, and generous paid time off, including hobby days and mental health days. They also provide paid travel to conferences and hackathons in Europe and the US and regular team off-sites across Europe to encourage team building and collaboration.

Molecule AG is a decentralized biotech protocol building a web3 marketplace for research-related intellectual property (IP). Their platform connects academics and biotech companies with quick and easy funding, while enabling patient, researcher, and funder communities to directly govern and own research-related IP. They are dedicated to empowering science and impacting humanity by accelerating the development of new therapeutics and making research more transparent and accessible.

Molecule AG promotes a collaborative and community-driven culture that emphasizes transparency and inclusivity. The company encourages open communication and knowledge sharing between researchers, funders, and the wider community, fostering a collaborative environment to accelerate scientific breakthroughs. Molecule is passionate about democratizing access to healthcare and empowering individuals to participate in the development of new therapeutics, creating a more equitable and impactful future.

Molecule AG is committed to building a diverse, equitable, and inclusive workplace. They believe in fostering an environment where individuals from all backgrounds feel welcomed, respected, and empowered to contribute their unique talents and perspectives. This commitment is reflected in their diverse leadership team, their efforts to attract and retain talent from underrepresented groups, and their ongoing initiatives to create a culture of belonging. They are also dedicated to supporting research projects that benefit all of humanity and promote scientific discoveries that can improve healthcare and address environmental challenges.